Safety and Tolerability of Anti-IL-20 in Healthy Volunteers and Patients With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this clinical trial is to investigate the
safety and tolerability of single doses of Anti-IL-20 in healthy volunteers (HV) and patients
with rheumatoid arthritis (RA).